Healthicare Tirzepatide Review: Cost, a Named Clinician & Honest Verdict (2026)

Healthicare: $264/month for tirzepatide, plus a genuinely named pharmacy — Jungle Jim's Pharmacy — and a named clinical lead, Dr. Jonah Mink, both independently checkable. Every fact here comes from the company's own published program.

What Healthicare is

Healthicare is a GLP-1 telehealth platform, offering both compounded options and a full brand-name menu — Ozempic, Wegovy, Mounjaro, and Zepbound — on a single account. Its named pharmacy partner is Jungle Jim's Pharmacy (F&F Pharmacies Inc.) in Fairfield, OH — the same pharmacy named by EOS Health, another provider reviewed on this site. Its named clinical lead is Dr. Jonah Mink, associated with Beluga Health — the same clinical network behind Coby Health and Curve elsewhere in this site. Shared third-party infrastructure across independently branded platforms is a common industry pattern, not evidence of a duplicate.

What Healthicare costs

$264/month for tirzepatide, with compounded semaglutide from $147.90/month on a 3-month plan ($174/month billed monthly) — genuinely at the lower end of the compounded segment. brand-name first-month pricing runs $1,199.99-$1,299.99 — at or above cash retail, so the real value here is on the compounded tier, not the brand one.

A footer naming question

Healthicare's footer references "Sunshine Health Studios Inc." — this review confirmed that reference is present, but the relationship between that entity and the healthicare.com domain owner isn't made clear on the site.

The brand-vs-compounded question

Healthicare offers both compounded tirzepatide and a genuine brand-name menu. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials; brand tirzepatide (Zepbound/Mounjaro) is the exact molecule and dose that was. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Healthicare's real strengths: a named pharmacy partner and named clinical lead — both independently checkable — both compounded and full brand-name options on one account, and compounded semaglutide at the lower end of the category. The trade-offs: not available in several states including California, Nevada, New Jersey, North Carolina, Texas, and Massachusetts; brand-name pricing runs at or above cash retail; and there's a footer naming discrepancy worth clarifying directly. As with any GLP-1 program, verify your state's coverage first, and compare the brand-name price against LillyDirect's own rate before choosing that tier; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Healthicare's named pharmacy and clinician are genuine, checkable transparency strengths this review confirmed directly, and the compounded semaglutide pricing is genuinely competitive — just skip the brand tier, which runs at or above cash retail. If you want brand access at a better price, compare LillyDirect directly in our Zepbound cost and savings guide. See our best tirzepatide providers ranking for the full field.